Apollo Hospitals confirms ₹1,942 cr PAT — a routine filing
The audited annual results add no new material information; the headline numbers and strategic deals were disclosed hours earlier.
— 2 earlier stories on Apollo Hospitals Enterprise Ltd. →What's new with Apollo Hospitals Enterprise Ltd.
- Audited results confirm revenue of ₹25,229 cr and PAT of ₹1,942 cr, in line with prior disclosure.
- Final dividend recommended; reappointment of Dr. Prathap C Reddy and Ms. Rama Bijapurkar approved.
- No material new information beyond the earlier board meeting outcome.
Why this matters for Apollo Hospitals Enterprise Ltd.
For a large cap with a market cap of ₹116,446 crores, confirmatory filings of already-announced numbers carry minimal market impact. The real story — the Cloudnine acquisition and subsidiary merger — was already priced in. This filing is procedural, not informational.
What we're watching
- Integration milestones for the Cloudnine network.
- Subsidiary merger execution and timeline.
- Q1 FY27 performance — whether operational trends sustain.
The full read
Apollo Hospitals' detailed annual results add nothing the market didn't already know. The consolidated revenue of ₹25,229 crore and PAT of ₹1,942 crore, along with the Cloudnine deal and subsidiary merger, were fully disclosed in the earlier board outcome on the same day. What the filing does contain is the final audit opinion, the dividend recommendation, and the routine reappointments of Dr. Prathap C Reddy and Ms. Rama Bijapurkar. For a company with a market cap of ₹116,446 crores, these are standard governance steps. The market had already reacted to the headline numbers; this is the paperwork that confirms them. The forward drivers — Cloudnine integration and organic utilisation trends — remain unchanged.